Mastodawn

Christophe Veltsos Sep 21, 2024

Here's the link to the FDA press release mentioned in the post above: FDA Approves Nasal Spray Influenza Vaccine for Self- or Caregiver-Administration www.fda.gov/news-events/... #FluVaccine

FDA Approves Nasal Spray Influ...

FDA Approves Nasal Spray Influenza Vaccine for Self- or Caregiver-Administration

FDA approves FluMist for self- or caregiver-administration. FluMist is approved for use in individuals 2 through 49 years of age for the prevention of influenza

U.S. Food and Drug Administration